This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Donaldson, S. S. Articles by Fisher, P. G. Search for Related Content PubMed PubMed Citation Articles by Donaldson, S. S. Articles by Fisher, P. G.

Advances Toward an Understanding of Brainstem Gliomas

From the Department of Radiation Oncology; Department of Pediatrics, Neurology, and Neurosurgery, Stanford University School of Medicine, Stanford, CA; and the Department of Radiological Sciences, St Jude Children's Research Hospital, Memphis, TN

Address reprint requests to Sarah S. Donaldson, MD, Department of Radiation Oncology, Stanford University School of Medicine, 875 Blake Wilbur Dr, MC: 5847, Stanford, CA 94305; e-mail: sarah{at}reyes.stanford.edu

The diagnosis of brainstem glioma was long considered a single entity. However, since the advent of magnetic resonance imaging in the late 1980s, neoplasms within this anatomic region are now recognized to include several tumors of varying behavior and natural history. More recent reports of brainstem tumors include diverse sites such as the cervicomedullary junction, pons, midbrain, or the tectum. Today, these tumors are broadly categorized as either diffuse intrinsic gliomas, most often in the pons, or the nondiffuse brainstem tumors originating at the tectum, focally in the midbrain, dorsal and exophytic to the brainstem, or within the cervicomedullary junction. Although we briefly discuss the nondiffuse tumors, we focus specifically on those diffuse brainstem tumors that regrettably still carry a bleak prognosis.

Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.

This article has been cited by other articles:

				D. A. Haas-Kogan, A. Banerjee, M. Kocak, M. D. Prados, J. R. Geyer, M. Fouladi, T. McKnight, T. Y. Poussaint, A. Broniscer, S. M. Blaney, et al. Phase I trial of tipifarnib in children with newly diagnosed intrinsic diffuse brainstem glioma Neuro-oncol, January 1, 2008; 10(3): 341 - 347. [Abstract] [Full Text] [PDF]

				J. George, C. S. Gondi, D. H. Dinh, M. Gujrati, and J. S. Rao Restoration of Tissue Factor Pathway Inhibitor-2 in a Human Glioblastoma Cell Line Triggers Caspase-Mediated Pathway and Apoptosis Clin. Cancer Res., June 15, 2007; 13(12): 3507 - 3517. [Abstract] [Full Text] [PDF]

				T. Y. Poussaint, P.C. Phillips, S. Vajapeyam, F.H. Fahey, R.L. Robertson, S. Osganian, U. Ramamurthy, R.V. Mulkern, S.T. Treves, J.M. Boyett, et al. The Neuroimaging Center of the Pediatric Brain Tumor Consortium-Collaborative Neuroimaging in Pediatric Brain Tumor Research: A Work in Progress AJNR Am. J. Neuroradiol., April 1, 2007; 28(4): 603 - 607. [Abstract] [Full Text] [PDF]

				T. S. Lawrence, J. C. Buckner, and F. F. Lang CNS Malignancies: At Last, Real Progress J. Clin. Oncol., March 10, 2006; 24(8): 1225 - 1227. [Full Text] [PDF]